search
Back to results

Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects

Primary Purpose

Localized Aggressive Periodontitis

Status
Unknown status
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
periodontal regenerative surgery
Sponsored by
Tanta University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Localized Aggressive Periodontitis focused on measuring Nigella Sativa oil extract, Localized Aggressive Periodontitis

Eligibility Criteria

18 Years - 30 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • systemically healthy patients were selected

    • patients who had not received any medications for the previous six months that may interfere with periodontal tissue health or healing.
    • Patients should demonstrate their ability to maintain good oral hygiene

Exclusion Criteria:

  • • Smokers and pregnant patients.

    • Medically compromised patients and systemic conditions precluding periodontal surgery.
    • Subjects who do not comply with oral hygiene measures as evidenced in recall visits.
    • Restoration or caries in the site to be treated or non-vital tooth
    • Restoration or caries in the site to be treated or non-vital tooth

Sites / Locations

  • Doaa Ahmed yousef bayoumi

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

test group

control group

Arm Description

10 infrabony defects treated surgically with Nigella Sativa oil extract Mixed with xenograft

10 infrabony defects treated surgically with xenograft alone

Outcomes

Primary Outcome Measures

probing pocket depth
probing pocket depth probing pocket depth will be recorded at baseline, 3, and 6 months at the site to be treated
clinical attachment level
clinical attachment level will be recorded at baseline, 3, and 6 months at the site to be treated
bleeding on probing
bleeding on probing will be recorded at baseline, 3, and 6 months at the site to be treated
cone beam x ray measuring bone fill
bone fill will be recorded at baseline, and 6 months at the site to be treated

Secondary Outcome Measures

Full Information

First Posted
January 13, 2021
Last Updated
July 31, 2021
Sponsor
Tanta University
search

1. Study Identification

Unique Protocol Identification Number
NCT04722380
Brief Title
Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects
Official Title
Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects: a Combined Clinical and Histological Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
December 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tanta University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study will be to evaluate, clinically, and radiographically the effect of Nigella Sativa oil extract Mixed with xenograft versus xenograft alone in the treatment of intra-bony defects in patients with aggressive periodontitis.
Detailed Description
in 10 patients, twenty sites in subjects with, localized aggressive periodontitis, with CAL ≥ 5 will be included in the present study. Sites will be allocated randomly to be surgically treated with, Nigella Sativa oil extract Mixed with xenograft or xenograft alone. At baseline, 3, 6 after surgery, the following clinical parameters (PD, CAL, BOP) and CBCT at baseline and 6 months x-ray will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Localized Aggressive Periodontitis
Keywords
Nigella Sativa oil extract, Localized Aggressive Periodontitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
10 patients, twenty sites with, localized aggressive periodontitis, with CAL ≥ 5 will be included in the present study. Sites will be allocated randomly to be surgically treated with, Nigella Sativa oil extract Mixed with xenograft or xenograft alone.
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
test group
Arm Type
Experimental
Arm Description
10 infrabony defects treated surgically with Nigella Sativa oil extract Mixed with xenograft
Arm Title
control group
Arm Type
Placebo Comparator
Arm Description
10 infrabony defects treated surgically with xenograft alone
Intervention Type
Procedure
Intervention Name(s)
periodontal regenerative surgery
Other Intervention Name(s)
periodontal surgery
Intervention Description
Procedure/Surgery: open flap debridement Open flap for removal of diseased periodontal tissues and necrotic cementum , using xenogenic bone graft with or without Nigella Sativa oil extract
Primary Outcome Measure Information:
Title
probing pocket depth
Description
probing pocket depth probing pocket depth will be recorded at baseline, 3, and 6 months at the site to be treated
Time Frame
6 months
Title
clinical attachment level
Description
clinical attachment level will be recorded at baseline, 3, and 6 months at the site to be treated
Time Frame
6 months
Title
bleeding on probing
Description
bleeding on probing will be recorded at baseline, 3, and 6 months at the site to be treated
Time Frame
6 months
Title
cone beam x ray measuring bone fill
Description
bone fill will be recorded at baseline, and 6 months at the site to be treated
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: systemically healthy patients were selected patients who had not received any medications for the previous six months that may interfere with periodontal tissue health or healing. Patients should demonstrate their ability to maintain good oral hygiene Exclusion Criteria: • Smokers and pregnant patients. Medically compromised patients and systemic conditions precluding periodontal surgery. Subjects who do not comply with oral hygiene measures as evidenced in recall visits. Restoration or caries in the site to be treated or non-vital tooth Restoration or caries in the site to be treated or non-vital tooth
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
doaa bayoumi, PHD
Organizational Affiliation
Tanta University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Doaa Ahmed yousef bayoumi
City
Tanta
State/Province
Gharbiya
ZIP/Postal Code
31511
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects

We'll reach out to this number within 24 hrs